What this means
Injectable peptides are increasingly used without prescriptions for cosmetic and athletic enhancement, driven by digital marketing and social media. While evidence-based, FDA-approved peptides like semaglutide and tirzepatide offer significant clinical benefits under medical supervision, an expanding illicit market provides easy access without a prescription to many unapproved experimental drugs.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- People
- Kind of research
- A summary of earlier studies
The science
- Original title
- Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.
- Authors
- Moiz A, O'Keefe EL, O'Keefe JH
- Journal
- Missouri medicine
- Published
- Sep 18, 2026
- Study type
- Review · in humans
- PMID
- 42757290 ↗
Abstract
Injectable peptides are increasingly used without prescriptions for cosmetic and athletic enhancement, driven by digital marketing and social media. While evidence-based, FDA-approved peptides like semaglutide and tirzepatide offer significant clinical benefits under medical supervision, an expanding illicit market provides easy access without a prescription to many unapproved experimental drugs. These unregulated substances-including the veterinary anabolic steroid trenbolone, investigational triple-agonists like retatrutide, and unapproved peptides such as BPC-157, TB-500, and melanotan-II-lack established human safety profiles. Their use introduces severe potential risks, including product contamination, manufacturing impurities, inaccurate dosing, pathological angiogenesis, carcinogenesis, cardiovascular stress, and supraphysiological hormonal signaling. This review differentiates evidence-based therapeutics from unproven, high-risk compounds and outlines the molecular mechanisms of toxicity associated with popular "looksmaxxing" injectables. Clinicians must recognize these trends, and counsel patients on potential long-term health hazards of these potent agents.
Moiz A, O'Keefe EL, O'Keefe JH Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs. Missouri medicine. 2026. PMID: 42757290. https://pubmed.ncbi.nlm.nih.gov/42757290/
Related research
Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome.
BACKGROUND: Diabetic foot syndrome (DFS) is characterized by chronic inflammation, thrombotic imbalance, and impaired wound healing, yet systemic molecular alterations underlying this complication remain incompletely…
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.
Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance.
A modified form of thymosin beta 4 helped heart tissue after heart attack in animals
Researchers changed a protein so it stays in the body longer and tested it for heart attack damage. This study was done in animals, so it does not show the same effect in people.
Lessons from dog lifespan therapeutics for their human companions.
The growing evidence that existing cardio-renal-metabolic therapies, such as GLP-1 receptor agonists and SGLT2 inhibitors, confer all-cause mortality benefits has positioned them as the first wave of potential…
Energy devices for facial aging linked to GLP-1 drugs: a review of ideas
This review proposes ideas for research on energy-based skin devices in people taking GLP-1 drugs. It does not show that any device is safe or works for this group.
Semaglutide may slow some biological aging clocks in adults with HIV
In a trial of 84 adults, semaglutide was linked to slower aging scores on several blood-based measures. This was an extra analysis not planned at the start, so it cannot prove the drug slows aging.
See all research on GLP-1 drugs →